Review of anti-diabetic medicinal plant used in traditional medicine

Journal of Medicinal Plants

Volumn 5, Issue SUPPL. 2, 2006, Pages 1-8

  Fallah Huseini, H ^a   Fakhrzadeh, H ^b   Larijani, B ^b   Shikh Samani, A H ^c  

^a Institute of Medicinal Plants Iran   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

Author keywords

Diabetes; Medicinal plant; Traditional medicine

Indexed keywords

ANTIDIABETIC AGENT; ATRIPLEX HALIMUS EXTRACT; CAMELLIA SINENSIS EXTRACT; COLOCYNTH; FLAVONOID; GARLIC EXTRACT; GINKGO BILOBA EXTRACT; GLUCOSE; GYMNEMA SYLVESTRE EXTRACT; HERBACEOUS AGENT; INSULIN; MAMORDICA CHARANTIA EXTRACT; ONION EXTRACT; SECURIGERA SECURIDACA EXTRACT; SILYBUM MARIANUM EXTRACT; TRIGONELLA FOENUM GRAECUM EXTRACT; UNCLASSIFIED DRUG; VACCINIUM MYRTILLUS EXTRACT;

ALTERNATIVE MEDICINE; ATRIPLEX; BLOOD GLUCOSE MONITORING; DIABETIC PATIENT; DIET THERAPY; FEEDING BEHAVIOR; FENUGREEK; GARLIC; GINKGO BILOBA; GLUCOSE BLOOD LEVEL; GYMNEMA SYLVESTRE; HERBAL MEDICINE; HUMAN; INDUSTRIALIZATION; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LIFESTYLE; MAMORDICA CHARANTIA; MEDICINAL PLANT; NON INSULIN DEPENDENT DIABETES MELLITUS; ONION; PHYSICIAN; REVIEW; SECURIGERA SECURIDACA; SILYBUM MARIANUM; TEA; TRADITIONAL MEDICINE; VACCINIUM MYRTILLUS;

ALLIUM CEPA; ALLIUM SATIVUM; ATRIPLEX HALIMUS; CAMELLIA SINENSIS; CITRULLUS COLOCYNTHIS; CORONILLA SECURIDACA; GINKGO BILOBA; GYMNEMA SYLVESTRE; SILYBUM MARIANUM; TRIGONELLA FOENUM-GRAECUM; VACCINIUM MYRTILLUS;

EID: 33745066912     PISSN: 2717204X     EISSN: 27172058     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. DeFronzo RA. Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Review 1997; 5: 177 -269.
2. Hughs T, Gwynne J and Switzer B. Effects of caloric restriction and weight loss on glycemic control, insulin release and resistance and atherosclerotic risk in obese patients with type II diabetes mellitus. Am. J. Med. 1984; 77: 7-17.
3. Meigs JB. Epidemiology of the metabolic syndrome. Am. J. Manag. Care. 2002; (Suppl.11): S283-92; quiz S293-6.
4. Scherbaum WA. Insulin therapy in Europe. Diabetes Metab. Res. Rev. 2002; 18 Suppl 3: S50-S56.
5. Reddy SS. Health outcomes in type 2 diabetes. Int. J. Clin. Pract. Suppl. 2000; 113: 46-53.
6. Maries RJ. and Farnsworth NR. Antidiabetic plants and their active constituents. Phytomedicine. 1995; 12: 137-165.
7. Sheela CG and Augusti KT. Antidiabetic effects of S-allyl cysteine sulphoxide isolated from garlic (Allium sativum L.). Indian J. Exp. Biol. 1992; 30: 523-526.
8. Sharma KK, Gupta RK, Gupta S and Samuel KC. Antihyperglycemic effect of onion: effect on fasting blood sugar and induced hyperglycemia in man. Ind. J. Med. Res. 1977; 65: 422-429.
9. Welihinda J, Karunanaya EH, Sheriff MHR and Jayasinghe KSA. Effect of Momardica charantia on the glucose tolerance in maturity onset diabetes. J. Ethnopharmacol. 1986; 17: 277-282.
10. Srivastava Y, Venkatakrishna-Bhatt H and Verma Y. Antidiabetic and adaptogenic properties of Momordica charantia extract: An experimental and clinical evaluation. Phytotherapy Res. 1993; 7: 285-289.
11. Welihinda J, Arvidson G, Gylfe E, Hellman B and Karlsson E. The insulin-releasing activity of the tropical plant Momordica charantia. Acta Biol. Med. Germ. 1982; 41: 1229-1240.
12. Shanmugasundaram ERB, Rajeswari G, Baskaran K, Rajesh Kumar BR, Shanmugasundaram K and Kizar Ahmath B. Use of Gymnema sylvestre leaf extract in the control of blood glucose in insulin dependent diabetes mellitus. J. Ethnopharmacol. 1990; 30: 281-294.
13. Baskaran K, Ahamath BK, Shanmugasundaram KR and Shanmugasundaram ERB. Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin dependent diabetes mellitus patients. J. Ethnopharmacol. 1990; 30: 295-305.
14. Mada Z, Abel R, Samish S and Arad J. Glucose-lowering effect of fenugreek in non-insulin dependent diabetics. Eur. J. Clin. Nutr. 1988; 42: 51-54.
15. Ribes G, Sauvaire Y, Baccou JC, Valette G, Chenon D, Trimble ER and Loubatieres-Mariani MM. Effects of fenugreek seeds on endocrine pancreatic secretions in dogs. Ann. Nutr. Metab. 1984; 28: 37-43.
16. Sharma RD, Raghuram TC and Rao NS. Effect of fenugreek seeds on blood glucose and serum lipids in type I diabetes. Eur. J. Clin. Nutr. 1990; 44: 301-306.
17. Stern E. Successful use of Atriplex halimus in the treatment of type II diabetic patients. A preliminary study. Unpublished study conducted at the Zamenhoff Medical Center, Tel Aviv, Israel. Unpublished study.
18. Murray M. Bilberry (Vaccinium myrtillus). American Journal of Natural Medicine. 1997; 4: 18-22.
19. Bever B and Zahnd G. Plants with oral hypoglycemic action. Quart. J. Crude Drug Res 1979; 17: 139-196.
20. Passariello N, Bisesti V and Sgambato S. Influence of anthocyanosides on the microcirculation and lipid picture in diabetic and dyslipidic subjects. Gazz. Med. Ital. 1979; 138: 563-566.
21. Kleijnen J and Knipschild P. Ginkgo biloba for cerebral insufficiency. Br. J. Clin. Pharm. 1992; 34: 352-358.
22. Funfgeld EW (ed): Rokan (Ginkgo biloba)-Recent Results in Pharmacology and Clinic. Springer-Verlag, New York, 1988; pp: 32-36.
23. Bauer U: 6-Month double-blind randomized clinical trial of Ginkgo biloba extract versus placebo in two parallel groups in patients suffering from peripheral arterial insufficiency. Arzneim-Forsch. 1984; 34: 716-721.
24. Campos R, Garrido A, Guerra R and Valenzuela A. Silybin dihemsuccinate protects against glutathioine depletion and lipid peroxidation induced by acetaminophen on rat liver. Plant Medica. 1998; 55: 417-419.
25. Velussi M, Cernigoi AM, De Monte A, Dapas F, Caffau C and Zilli M. Long-term (12 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients. J. Hepatol. 1997; 26: 871-879.
26. Lirussi F, Beccarello A, Zanette G, De Monte A, Donadon V, Velussi M and Crepaldi G. Silybin-beta-cyclodextrin in the treatment of patients with diabetes mellitus and alcoholic liver disease. Efficacy study of a new preparation of an anti-oxidant agent. Diabetes Nutr. Metab. 2002; 15: 222-231.
27. Packer L, Rosen P, Tritschler H, King GL and Azzi A (Eds): Antioxidants and Diabetes Management. New York, Marcel Dekker, 2000.
28. Rahman MA, Mossa JS, Al-Said MS and Al-Yahya MA. Medicinal plant diversity in the flora of Saudi Arabia 1: a report on seven plant families. Fitoterapia. 2004; 15: 149-161.
29. Abdel-Hassan IA, Abdel-Barry JA and Tariq Mohammeda S. The hypoglycaemic and antihyperglycaemic effect of Citrullus colocynthis fruit aqueous extract in normal and alloxan diabetic rabbits. J. Ethnopharmacol. 2000; 71: 325-330.
30. Ziyyat A, Legssyer A, Mekhfi H, Dassouli A, Serhrouchni M and Benjelloun W. Phytotherapy of hypertension and diabetes in oriental Morocco. J. Ethnopharmacol. 1997; 58: 45-54.
31. Goldfain D, Lavergne A, Galian A, Chauveinc L and Prudhomme F. Peculiar acute toxic colitis after ingestion of colocynth: a clinicopathological study of three cases. Gut 1989; 30: 1412-1418.
32. Ali AA, Mohamed MH, Kame MS, Fouad MA and Spring O. Studies on Securigera securidace L. Deg. Et Dörfl. (Fabacea) seeds, an antidiabetic Egyptian folk medicine. Pharmazie. 1998; 53: 710-715.
33. Hisseinzadeh H, Ramezani M and Danaei AR. Antihyperglycaemic effect and acute toxicity of Securigera secuidaca L. seed extracts in mice. Phytotherapy Research. 2002; 16: 745-747.
34. Porchezhian E and Ansari SH. Effects of Securigera securidaca on blood glucose levels of normal and alloxan-induced diabetic rats. Pharmaceutical Biology. 2001; 39: 62-64.
35. Guo Q, Zhao B, Shen S, Hou J, Hu J and Xin W. ESR study on the structure-antioxidant activity relationship of tea catechins and their epimers. Biochim. Biophys. Acta. 1999; 14, 1427: 13-23.
36. Sabu SM, Smitha K and Kuttan R. Anti-diabetic activity of green tea polyphenols and their role in reducing oxidative stress in experimental diabetes. J. Ethnopharmacol. 2002; 83: 109-116.
37. Wu LY, Juan CC, Hwang LS, Hsu YP, Ho PH and Ho LT. Green tea supplementation ameliorates insulin resistance and increases glucose transporter IV content in a fructose-fed rat model. Eur. J. Nutr. 2004; 43: 116-124.
38. Tsuneki H, Ishizuka M, Terasawa M, Wu JB, Sasaoka T and Kimura I. Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans. BMC Pharmacol. 2004; 4: 18.
39. Hii CS and Howell SL. Effects of flavonoids on insulin secretion and 45Ca2+ handling in rat islets of Langerhans. J. Endocrinol. 1985; 107: 1-8.
40. Sakai I, Izumi SI, Murano T, Okuwaki S, Makino T and Suzuki T. Presence of aldose reductase inhibitors in tea leaves. Jpn. J. Pharmacol. 2001; 85: 322-326.
41. Craig WJ. Health-promoting properties of common herbs. Am. J. Clin. Nutr. 1999; 70: 491S-499S.
42. Kuhnau J. The flavonoids. A class of semi-essential food components: their role in human nutrition. World. Rev. Nutr. Diet. 1976; 24: 117-191.
43. Arabbi PR, Genovese MI and Lajolo FM. Flavonoids in vegetable foods commonly consumed in Brazil and estimated ingestion by the Brazilian population. J. Agric. Food Chem. 2004; 52: 1124-1131.
44. Knekt P, Kumpulainen J, Jarvinen R, Rissanen H, Heliovaara M, Reunanen A, Hakulinen T and Aromaa A. Flavonoid intake and risk of chronic diseases. Am. J. Clin. Nutr. 2002; 76: 560-568.